186 related articles for article (PubMed ID: 17326019)
1. Attributable mortality of nosocomial Acinetobacter bacteremia.
Grupper M; Sprecher H; Mashiach T; Finkelstein R
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
[TBL] [Abstract][Full Text] [Related]
3. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
5. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine.
Al Jarousha AM; El Jadba AH; Al Afifi AS; El Qouqa IA
Int J Infect Dis; 2009 Sep; 13(5):623-8. PubMed ID: 19144555
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in Acinetobacter baumannii bacteremia.
Chen HP; Chen TL; Lai CH; Fung CP; Wong WW; Yu KW; Liu CY
J Microbiol Immunol Infect; 2005 Apr; 38(2):127-36. PubMed ID: 15843858
[TBL] [Abstract][Full Text] [Related]
8. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.
Wang YC; Lee YT; Yang YS; Chen CT; Chiu CH; Yin T; Kuo SC; Chen TL; Lin JC; Wang FD; Fung CP; Chang FY
Clin Microbiol Infect; 2015 Aug; 21(8):758-64. PubMed ID: 25980356
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.
Blot S; Vandewoude K; Colardyn F
Intensive Care Med; 2003 Mar; 29(3):471-5. PubMed ID: 12577148
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
13. High mortality associated with Acinetobacter species infection in liver transplant patients.
Kim YJ; Yoon JH; Kim SI; Hong KW; Kim JI; Choi JY; Yoon SK; You YK; Lee MD; Moon IS; Kim DG; Kang MW
Transplant Proc; 2011; 43(6):2397-9. PubMed ID: 21839276
[TBL] [Abstract][Full Text] [Related]
14. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].
Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U
Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.
Seifert H; Strate A; Pulverer G
Medicine (Baltimore); 1995 Nov; 74(6):340-9. PubMed ID: 7500897
[TBL] [Abstract][Full Text] [Related]
16. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
Pradhan NP; Bhat SM; Ghadage DP
J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
Vitkauskiene A; Dambrauskiene A; Cerniauskiene K; Rimdeika R; Sakalauskas R
Scand J Infect Dis; 2013 Mar; 45(3):213-8. PubMed ID: 23113773
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of and risk factors for Acinetobacter species bloodstream infection in children.
Segal SC; Zaoutis TE; Kagen J; Shah SS
Pediatr Infect Dis J; 2007 Oct; 26(10):920-6. PubMed ID: 17901798
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.
Wisplinghoff H; Edmond MB; Pfaller MA; Jones RN; Wenzel RP; Seifert H
Clin Infect Dis; 2000 Sep; 31(3):690-7. PubMed ID: 11017817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
